← FDA DRUG APPROVALS

FDA ANDA · ANDA075206

CYTOSAR-U

Sponsor: TEVA PHARMS USA

APPLICATION
ANDA075206
TYPE
ANDA
ORIGINAL APPROVAL
1998-12-30
LATEST ACTION
1998-12-30
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CYTOSAR-UDiscontinued
CYTARABINE 2GM/VIAL · INJECTABLE · INJECTION
CYTOSAR-UDiscontinued
CYTARABINE 100MG/VIAL · INJECTABLE · INJECTION
CYTOSAR-UDiscontinued
CYTARABINE 1GM/VIAL · INJECTABLE · INJECTION
CYTOSAR-UDiscontinued
CYTARABINE 500MG/VIAL · INJECTABLE · INJECTION

Approval history

1998-12-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →